# Mismatched Donor Cells to Treat Acute Myeloid Leukemia

> **NCT01793025** · PHASE1 · UNKNOWN · sponsor: **Maisonneuve-Rosemont Hospital** · enrollment: 12 (estimated)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **BIOLOGICAL:** ATAC Therapy

## Key facts

- **NCT ID:** NCT01793025
- **Lead sponsor:** Maisonneuve-Rosemont Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-09
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2017-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01793025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01793025, "Mismatched Donor Cells to Treat Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01793025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*